医学
免疫疗法
肝癌
肿瘤科
癌症
内科学
肝细胞癌
癌症研究
无容量
临床试验
免疫系统
标识
DOI:10.3760/cma.j.cn501113-20210622-00297
摘要
In recent years, immunotherapy has achieved remarkable effectiveness for liver cancer and has attracted much attention, especially the combination therapy based on immune checkpoint blockers. Multidisciplinary experts have written the Chinese multidisciplinary expert consensus on combined immunotherapy based on immune checkpoint inhibitors for hepatocellular carcinoma (2021 version), which provides reference guidance for clinically relevant professionals to grasp indications, strengthen monitoring, timely and effective treatment of adverse reactions, and formulate reasonable combined treatment plan.
科研通智能强力驱动
Strongly Powered by AbleSci AI